LCD Reference Article Response To Comments Article

Response to Comments: Intraosseous Basivertebral Nerve Ablation

A59598

Expand All | Collapse All

Contractor Information

Contractor Name	Contract Type	Contract Number	Jurisdiction	States
Noridian Healthcare Solutions, LLC	A and B MAC	01111 - MAC A	J - E	California - Entire State
Noridian Healthcare Solutions, LLC	A and B MAC	01112 - MAC B	J - E	California - Northern
Noridian Healthcare Solutions, LLC	A and B MAC	01182 - MAC B	J - E	California - Southern
Noridian Healthcare Solutions, LLC	A and B MAC	01211 - MAC A	J - E	American Samoa Guam Hawaii Northern Mariana Islands
Noridian Healthcare Solutions, LLC	A and B MAC	01212 - MAC B	J - E	American Samoa Guam Hawaii Northern Mariana Islands
Noridian Healthcare Solutions, LLC	A and B MAC	01311 - MAC A	J - E	Nevada
Noridian Healthcare Solutions, LLC	A and B MAC	01312 - MAC B	J - E	Nevada
Noridian Healthcare Solutions, LLC	A and B MAC	01911 - MAC A	J - E	American Samoa California - Entire State Guam Hawaii Nevada Northern Mariana Islands

Article Information

General Information

Article ID
A59598

Article Title
Response to Comments: Intraosseous Basivertebral Nerve Ablation

Article Type
Response to Comments

Original Effective Date
01/28/2024

Retirement Date
N/A

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Copyright © 2024, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Article Guidance

Article Text

During the 45-day comment period the A/B MAC received a total of 12 comments.

The A/B MACs appreciate the comments received from stakeholders during the open comment period on the proposed Intraosseous Basivertebral Nerve Ablation Local Coverage Determination (LCD).

Pursuant to the CMS Program Integrity Manual (CMS Pub. 100-08) Chapter 13:

In conducting a review, MACs shall use the available evidence of general acceptance by the medical community, such as published original research in peer-reviewed medical journals, systematic reviews and meta-analyses, evidence-based consensus statements and clinical guidelines.

Accordingly, the final policy and our response to comments are based on the best currently available published clinical evidence, in order to afford the most optimal opportunity for success in Medicare-eligible beneficiaries with Intraosseous Basivertebral Nerve Ablation.

Response To Comments

Number	Comment	Response
1	Commenter (1) disputes the need for psychological evaluation for patient’s proposed for treatment with BVN Ablation. (2) notes that pain generators may be multiple and overlap, suggesting that additional diagnoses in the region should not preclude individual treatment of each. Note: these 2 comments appear the dominant themes for which comments have been submitted. Subsequent inclusion of these comments will be referred to this response though noted separately.	(1) Agree that psychological evaluation may be redundant for a patient without documented psychological issues, however, these are not limited to functional problems and include long term drug abuse which, without competent therapy could mask symptoms and positive outcome of any procedure. In the absence of documented psychological disease and ongoing substance use or abuse or, in the instance of ongoing addiction or psychological evaluation, the physical finding of Modic changes correlating with signs and symptoms of basivertebral nerve irritation, additional psychological evaluation would be considered redundant. (2) Overlapping pain generators may dispute the need for therapy of each. It is recommended that the provider act upon documented signs and symptoms of disease, addressing each potential disease entity in an organized diagnostic pattern to determine the dominant impediment to the patient’s well-being, then address in descending order.
2	Patient reports longstanding LBP with 15-year history of some form of paraspinal RF ablation Q6 mos. in hope of reducing opioid and antispasmodic medications. Encourages continued exploration of therapeutic interventions for treatment	Comment noted.
3	(1) Suggests the requirement for Modic I or 2 changes noted on MRI would eliminate patients from treatment without these diagnostic elements and is inconsistent with inclusion criteria per NASS coverage recommendations. (2) See Above relative to psychological assessment. Suggests lack of necessity of interdisciplinary team, in depth psychological evaluation, with multiple evaluations which may lead to unnecessary delays in therapy as well as conflicting indications for inclusion for treatment. (3) Recommends removal of lifetime limit of one per vertebral body, stating that no current literature supports limitation.	(1) Modic 1 or 2 changes on MR imaging remain the only reproducible diagnostic criteria of BVN irritation as a source of pain per all literature evaluated. If the commenter has evidence to support alternative diagnostic elements either disputing this as diagnostic criteria or supporting alternative diagnosis suggested by Modic 1 or 2 images which would not benefit from BVN ablation, or alternative diagnostic testing with similar relevance for treatment indications, references should be submitted for reconsideration. (2) See above response for benefit of multidisciplinary exam including in depth psychological evaluation. Multidisciplinary exam includes both imaging as well as history and physical. Psychological exam is recommended secondary to the high incidence of substance dependence in the population presenting for BVN ablation. It is acknowledged that multiple pain management practices incorporate addiction management into therapeutic evaluation and management, such that it is included in the provider’s evaluation for treatment, which would meet this requirement of the LCD. (3) If data reference is available to support incidence of failed therapy due to incomplete ablation of BVN, or indication for repeat service, it should be submitted for reconsideration. With present data available BVN ablation should be complete without subsequent recurrence. When data support regeneration or incomplete ablation, reconsideration for repeat therapy should be requested.
4	Comment expresses consensus with Determination criteria but also questions need for psychological evaluation, recommending treatment based on findings and lack of response to conservative measures.	Comments appreciated. See above for response to need for psych eval.
5	Recommendations made consistent with LCD Draft suggest finalization with allowance of a single level per sessions of treatment and limitation to exclude other para vertebral injections or interventions in the same session.	We appreciate your recommendations based on the paucity of graded evidence to support use of this intervention. However, it is the feeling of Noridian that treatment should be allowed for documented findings consistent with intravertebral ischemia, edema and necrosis affecting the Basivertebral Nerve of that vertebral body. With evidence supporting at least 2 levels affected, it is inappropriate to restrict treatment to a single level, requiring the patient to return for repeat treatment that could have been more efficiently combined with the first. Noridian concurs with the restriction to a single type of spinal or paraspinal intervention at a single session same region, in that multiple types could mask benefit or confuse findings and outcome. This limitation will be included in the local coverage determination for JE and JF. Local anesthesia for the procedure would be included in the procedure and not billed separately. It is not expected the addition of steroids to benefit the patient or procedure. Inclusion may trigger review and potential denial as not reasonable and necessary per reimbursable guidelines. Thank you for your literature review and comment.
6	(1) Commentor suggests indication based on chronicity, failed treatment, and MRI changes with inclusion of expanded definitions for Modic changes covered. (2) Suggests deletion of extensive multidisciplinary screening as a requirement for treatment. (3) Requests deletion of contraindication posed by likely alternative etiology. (4) Does not feel generalized systemic disease such as morbid obesity should be contraindication to treatment; Similarly, does not feel ongoing substance abuse should restrict use in patients. Recommends the addition of three diagnosis codes for coverage with BVN ablation.	(1) Agree with initial comment regarding indications for treatment. (2) Will consider expansion of definitions of Modic 1 and 2 changes. (3) Contraindication to treatment with alternative or concomitant pathology affecting the targeted vertebral body is not deemed of advantage to the patient and could complicate treatment or diagnosis and outcome. No change is planned, though limitations may be further clarified. Similarly, it is recommended that concomitant conditions which may affect treatment outcome be carefully evaluated by the treating physician, including Morbid Obesity and ongoing Substance Abuse. Whereas these co-morbidities associated with BVN generated pain are not treatable by BVN ablation, improvement or outcome may be deterred, compromised, or masked by these issues. (4) The consideration of specific coding for diagnosis to procedure editing does not permit non-specific addition of marginally related diagnosis codes to the LCD or LCA. *Of note, this commentor has potential conflict of interest as stakeholder of marketed device utilized for this procedure.
7	Concurs with previous comments on the lack of benefit to diagnosis or outcome by multidisciplinary team or in-depth psychological evaluation as conditions for treatment.	Please see above comments. While there is little support for multiple evaluations to support BVN ablation, thorough psychological evaluation to assess benefit with ongoing untreated or non-optimized therapy for ongoing substance abuse or major psychiatric diagnoses is recommended for avoidance of intraprocedural as well as subsequent complications attributed to the procedure. Appreciate your confirmation of reasonable and necessary as a procedure for the stated diagnostic criteria of the Coverage Determination.
8	Expresses concern for the exclusion of patient with non-vertebral pathology that could contribute to symptoms and the requirement that patients undergo screening, evaluation, and diagnosis by a multidisciplinary team to include psychological and physical assessment.	While the cited bullet wording may seem excessive, most of these requirements are necessary for coverage of any service by Medicare or other health care insurer to assure the appropriateness of the service. It would be inappropriate to perform this procedure on a patient without first documenting the inciting etiology is not accompanied by a concomitant condition (tumor or fracture) which may potentially worsen these conditions. Recommended substitution for imaging documentation of the regional pain generator would seem appropriate along with the standard LCD requirements of a (documented) complete history and physical examination. Noridian concurs with the statement of intention of ruling out alternative pathology with alternative treatment if more appropriate. Due to the high incidence of ongoing substance dependence and abuse in patient with chronic back pain, or any form of chronic pain, the negative impact of this dependence must be considered prior to additional intervention. Should the physician’s pre-operative evaluation include such documentation (complete history and physical), requirements would be considered met.
9	Suggests similar feelings regarding assessment as above but adds the additional expense to the patient for multiple physician visits and extensive psychological testing.	See above. It is not the desire of Noridian to increase either provider or beneficiary financial burden. It would be expected that standard requirements of patient and disease documentation would include all aspects of evaluation necessary to safely provide this service to our Medicare beneficiaries who may benefit.
10	Recommends NASS language for evaluation of possible concomitant findings that may complicate or contraindicate the use of BVN ablation as the treatment for vertebrogenic back pain. As per other commentors, notes that patients usually have additional pathology that may contribute to back pain. Additional comment is that expressed by multiple providers and societies above: lack of benefit to multidisciplinary team evaluation.	Please see response to comments above.

Coding Information

Bill Type Codes

Code	Description
Please accept the License to see the codes.

Revenue Codes

Code	Description
Please accept the License to see the codes.

CPT/HCPCS Codes

Expand All | Collapse All

Please accept the License to see the codes.

ICD-10-CM Codes that Support Medical Necessity

Expand All | Collapse All

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Expand All | Collapse All

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

ICD-10-PCS Codes

Expand All | Collapse All

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

Additional ICD-10 Information

Bill Type Codes

Code	Description
Please accept the License to see the codes.

Revenue Codes

Code	Description
Please accept the License to see the codes.

Coding Table Information

Excluded CPT/HCPCS Codes - Table Format

Code	Descriptor Generic Name	Descriptor Brand Name	Exclusion Effective Date	Exclusion End Date	Reason for Exclusion
			N/A	N/A

Non-Excluded CPT/HCPCS Ended Codes - Table Format

Code	Descriptor Generic Name	Descriptor Brand Name	Exclusion Effective Date	Exclusion End Date	Reason for Exclusion

Revision History Information

N/A

Associated Documents

Related Local Coverage Documents
LCDs
L39642 - Intraosseous Basivertebral Nerve Ablation

Updated On	Effective Dates	Status
12/10/2023	01/28/2024 - N/A	Currently in Effect	You are here

Keywords

N/A

Read the Article Disclaimer

License Agreements
American Medical Association Current Procedural Terminology
American Dental Association Current Dental Terminology
American Hospital Association NUBC UB-04

Please review the licensing information below and indicate your agreement and acceptance.

License for Use of Current Procedural Terminology (CPT)

End User Point and Click Agreement: CPT codes, descriptions and other data only are copyright 2023 American Medical Association. All Rights Reserved (or such other date of publication of CPT). CPT is a trademark of the American Medical Association (AMA).

You, your employees, and agents are authorized to use CPT only as agreed upon with the AMA internally within your organization within the United States for the sole use by yourself, employees, and agents. Use is limited to use in Medicare, Medicaid or other programs administered by the Centers for Medicare and Medicaid Services (CMS). You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized herein must be obtained through the AMA, CPT Intellectual Property Services, AMA Plaza, 330 Wabash Ave., Suite 39300, Chicago, IL 60611-5885. Applications are available at the AMA Web site, http://www.ama-assn.org/go/cpt http://www.ama-assn.org/go/cpt.

Applicable FARS\DFARS Restrictions Apply to Government Use.

This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, AMA Plaza, 330 N. Wabash Ave., Suite 39300, Chicago, IL 60611-5885. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of FAR 52.227-14 (December 2007) and/or subject to the restricted rights provisions of FAR 52.227-14 (December 2007) and FAR 52.227-19 (December 2007), as applicable, and any applicable agency FAR Supplements, for non-Department of Defense Federal procurements.

The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT should be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS disclaims responsibility for any liability attributable to end user use of the CPT. CMS will not be liable for any claims attributable to any errors, omissions, or other inaccuracies in the information or material contained on this page. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

License For Use of Current Dental Terminology (CDT^TM)

The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. By clicking below on the button labeled "I accept", you hereby acknowledge that you have read, understood, and agreed to all terms and conditions set forth in this agreement.

If you do not agree with all terms and conditions set forth herein, click below on the button labeled "I do not accept" and exit from this computer screen.

If you are acting on behalf of an organization, you represent that you are authorized to act on behalf of such organization and that your acceptance of the terms of this agreement creates a legally enforceable obligation of the organization. As used herein, "you" and "your" refer to you and any organization on behalf of which you are acting.

Subject to the terms and conditions contained in this Agreement, you, your employees and agents are authorized to use CDT only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of CDT is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT for resale and/or license, transferring copies of CDT to any party not bound by this agreement, creating any modified or derivative work of CDT, or making any commercial use of CDT. License to use CDT for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Applications are available at the American Dental Association web site, http://www.ADA.org/ http://www.ADA.org/.

Applicable Federal Acquisition Regulation Clauses (FARS)/Department of Defense Federal Acquisition Regulation supplement (DFARS) Restrictions Apply to Government Use.

Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license.

ADA DISCLAIMER OF WARRANTIES AND LIABILITIES

CDT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values, or related listings are included in CDT. The ADA does not directly or indirectly practice medicine or dispense dental services. The sole responsibility for software, including any CDT and other content contained therein, is with (insert name of applicable entity) or the CMS; and no endorsement by the ADA is intended or implied. The ADA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The ADA is a third-party beneficiary to this Agreement.

CMS DISCLAIMER

The scope of this license is determined by the ADA, the copyright holder. Any questions pertaining to the license or use of the CDT should be addressed to the ADA. End Users do not act for or on behalf of the CMS. CMS disclaims responsibility for any liability attributable to end user use of the CDT. CMS will not be liable for any claims attributable to any errors, omissions, or other inaccuracies in the information or material covered by this license. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. If the foregoing terms and conditions are acceptable to you, please indicate your agreement by clicking below on the button labeled "I Accept". If you do not agree to the terms and conditions, you may not access or use software. Instead, you must click below on the button labeled "I Do Not Accept" and exit from this computer screen.

License For Use of National Uniform Billing Committee (NUBC) UB-04

These materials contain NUBC Official UB-04 Specifications (UB-04 Data), which is copyrighted by the American Hospital Association (AHA).

THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING BELOW ON THE BUTTON LABELED "I ACCEPT", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.

IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELED "I DO NOT ACCEPT" AND EXIT FROM THIS COMPUTER SCREEN. IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.

Subject to the terms and conditions contained in this Agreement, you, your employees, and agents are authorized to use UB-04 Data only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of UB-04 Data is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this Agreement. You acknowledge that the AHA holds all copyright, trademark, and other rights in UB-04 Data. You shall not remove, alter, or obscure any AHA copyright notices or other proprietary rights notices included in the materials.
Any use not authorized herein is prohibited, including, by way of illustration and not by way of limitation, making copies of UB-04 Data for resale and/or license, transferring copies of UB-04 Data to any party not bound by this agreement, creating any modified or derivative work of UB-04 Data, or making any commercial use of UB-04 Data. License to use UB-04 Data for any use not authorized herein must be obtained through the American Hospital Association, 155 N. Wacker Drive, Suite 400, Chicago, Illinois, 60606. Applications are available at the NUBC website, http://www.nubc.org/ http://www.nubc.org/.
The UB-04 Data included in this product is commercial technical data and/or computer databases and/or commercial computer software and/or commercial computer software documentation, as applicable, which was developed exclusively at private expense by the American Hospital Association, 155 N. Wacker Drive, Suite 400, Chicago, Illinois 60606. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2) (November 1995) and/or subject to the restrictions of DFARS 227.7202-1(a) (June 1995) and DFARS 227.7202-3(a) (June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (December 2007) and FAR 52.227-19 (December 2007), as applicable, and any applicable agency FAR Supplements, for non-Department of Defense Federal procurements.
AHA DISCLAIMER OF WARRANTIES AND LIABILITIES. UB-04 Data is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. The sole responsibility for the software, including any UB-04 Data and other content contained therein, is with the Medicare/Medicaid Contractor or the CMS; and no endorsement by the AHA is intended or implied. The AHA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The AHA is a third-party beneficiary to this Agreement.
CMS DISCLAIMER. The scope of this license is determined by the AHA, the copyright holder. Any questions pertaining to the license or use of the UB-04 Data should be addressed to the AHA. End users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE UB-04 DATA. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

Submit Feedback/Ask a Question

Response to Comments: Intraosseous Basivertebral Nerve Ablation

Document Note

Note History

Contractor Information

Article Information

General Information

CMS National Coverage Policy

Article Guidance

Response To Comments

Coding Information

Bill Type Codes

Please accept the License to see the codes.

Revenue Codes

Please accept the License to see the codes.

CPT/HCPCS Codes

Please accept the License to see the codes.

CPT/HCPCS Modifiers

Group 1

ICD-10-CM Codes that Support Medical Necessity

Group 1

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

ICD-10-PCS Codes

Group 1

Additional ICD-10 Information

Bill Type Codes

Please accept the License to see the codes.

Revenue Codes

Please accept the License to see the codes.

Other Coding Information

Group 1

Coding Table Information

Revision History Information

Associated Documents

Keywords

Page Help for Article - Response to Comments: Intraosseous Basivertebral Nerve Ablation (A59598)

Introduction

Finding a specific code

More information

Printing a Document to PDF

Get email updates

CMS & HHS WEBSITES

HELPFUL LINKS

RSS FEEDS